Those who applied for
Congratulations to everyone who applied for the free trial.
※ For those who missed the “COVID-19 treatment” opportunity, no worries. We are going out strong once again.
※ Finally starting. Telechips (054450) follow-up stock hits the upper limit on Monday ※
Humasis announced that it has received export approval from the Ministry of Food and Drug Safety for a rapid diagnostic kit that simultaneously detects antigens of the novel coronavirus and influenza virus!!
This product requires only one sample collection from the nasopharynx, the back of the patient's nose, and when reacted with the extraction solution, it can confirm COVID-19 and flu infection status within 15 minutes!!
▶▶ Heading straight ‘up’ on Monday. Moving fast. COVID-19 and flu simultaneous diagnostic kit!
“It was just too difficult to trade stocks alone.” I asked acquaintances for advice here and there, but I never made a proper profit even once. So I thought to get help from an expert and first applied for a 3-day free trial! Wow! Experts really are different. I am still receiving the service now, and looking back, I think it was a great decision. Thank you. (VIP office worker Kim Minji, 46 years old member)
▶▶ “October 5th upper limit” offered only until today and then closed.
[Receive stocks related to ‘COVID-19 and flu simultaneous diagnostic kit’!] ▶Receive stocks◀
Think of this as the last chance. If you miss this opportunity, you have to give up.
Exactly on “October 5th” it will explode! Don’t miss out and regret it, buy at least 1 million KRW worth!
▶▶ Only 30 people will be given. “Monday upper limit”! ▶Get it now◀
※ First-come, first-served 30 people limit! Both early and late rounds are over. The hero of the last injury time winning goal ※
[Today’s stocks of interest]
#BaxelBio #AprogenPharmaceutical #YoungjinPharmaceutical #CMGPharmaceutical #MyungmoonPharmaceutical
※ This content is unrelated to the editorial direction of Asia Economy, and all responsibility lies with the information provider.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
